Read + Share
Han BY, Chen C, Luo H, Lin CJ, et al. Clinical sequencing defines the somatic and germline mutation landscapes of
Chinese HER2-Low Breast Cancer. Cancer Lett 2024 Feb 23:216763. doi: 10.1016/j.canlet.2024.216763.
PMID: 38403109
|
 |
|
Han BY, Chen C, Luo H, Lin CJ, et al. Clinical sequencing defines the somatic and germline mutation landscapes of
Chinese HER2-Low Breast Cancer. Cancer Lett 2024 Feb 23:216763. doi: 10.1016/j.canlet.2024.216763.
PMID: 38403109
|
|
|
|